Prosecution Insights
Last updated: October 02, 2026

Fudan University

Technology area: Biotechnology & Pharmaceuticals

11 pending office actions • 8 art units • 10 examiners • 0 of 11 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days

Analysis

Fudan University currently manages 9 pending office actions, primarily within the Biotechnology & Pharmaceuticals technology area. This workload is distributed across 7 distinct art units, indicating a diverse range of technical subjects under review. The prosecution involves 9 distinct examiners, showing a high degree of fragmentation across the portfolio. Each pending matter is handled by a different individual, as the 9 actions are spread across 9 distinct examiners.

MEAH, MOHAMMAD Y is identified as the busiest examiner for the university, though they are responsible for 1 pending action. This specific examiner's workload matches the broader trend where no examiner holds a majority of the pending cases. Practitioners should prepare for varied examiner styles across the 7 different art units involved. The lack of concentration among examiners suggests that prosecution strategies may need to be tailored to the specific preferences of 9 different individuals.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

11
Total Pending OAs
8
Non-Final OAs
1
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (64%)
1
Medium (9%)
3
Easy (27%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (9%)
§103 only1 (9%)
§112 only3 (27%)
Multi-statute (no §101)6 (55%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
64% of docket
1
Information Tech
9% of docket
0
Communications
0% of docket
1
Semiconductors
9% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
18% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

110 h
Manual time on pending OAs
22 h
Time saved (low, 20%)
38 h
Time saved (mid, 35%)
1.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SAWYER, JENNIFER C 2 68.6% -8.4%
MEAH, MOHAMMAD Y 1 70.8% +42.7%
LIPPERT, JOHN WILLIAM 1 58.2% +40.0%
ABEL, GARY ROBERT 1 87.5% +11.0%
BAUER, BRIANNA LEE 1 100.0% +0.0%
MOUDOU, EILEEN QI-YUN 1 66.7% +0.0%
ALLEN, NICHOLAS E 1 75.6% +14.6%
HERNANDEZ, JACKSON J 1 51.4% +45.0%
MEJIAS, SAMANTHA LEE 1 46.4% +40.9%
WANG, CHANG YU 1 33.5% +53.5%

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18304987 USE OF FOLIC ACID AND FOLATE MODIFICATION IN INDUCING B-CELL IMMUNE TOLERANCE AND TARGETING mIgM-POSITIVELY-EXPRESSED B-CELL LYMPHOMA MEJIAS, SAMANTHA LEE 88d overdue
18520221 DATA SEARCH METHOD AND APPARATUS, AND DEVICE ALLEN, NICHOLAS E 21d
18717525 SMALL MOLECULE TRACERS BINDING TO ALPHA-SYNUCLEIN AGGREGATES AND THEIR USES LIPPERT, JOHN WILLIAM —
18716081 SPLIT-GATE SILICON CARBIDE DEVICE WITH BURIED FIELD LIMITING RING AND PREPARATION METHOD THEREOF ABEL, GARY ROBERT —
18707314 COMPOUNDS HAVING ACTIVITY OF DEGRADING GSPT1 AND APPLICATION THEREOF BAUER, BRIANNA LEE —
18285915 METHOD FOR PREPARING DEUTERATED CHEMICAL BY MEANS OF DEUTERATION REACTION OF CARBON-HYDROGEN BOND WITH DEUTERIUM GAS UNDER CATALYSIS OF ALKALI HERNANDEZ, JACKSON J —
18275291 PREPARATION METHOD FOR TETRA-SUBSTITUTED ALLENOIC ACID COMPOUND BASED ON PALLADIUM CATALYTIC SYSTEM SAWYER, JENNIFER C —

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18304987 USE OF FOLIC ACID AND FOLATE MODIFICATION IN INDUCING B-CELL IMMUNE TOLERANCE AND TARGETING mIgM-POSITIVELY-EXPRESSED B-CELL LYMPHOMA MEJIAS, SAMANTHA LEE 88d overdue
18520221 DATA SEARCH METHOD AND APPARATUS, AND DEVICE ALLEN, NICHOLAS E 21d
18885576 Three-dimensional model of exposed microbial membranes at gas-liquid interface and preparation method thereof MEAH, MOHAMMAD Y —
18717525 SMALL MOLECULE TRACERS BINDING TO ALPHA-SYNUCLEIN AGGREGATES AND THEIR USES LIPPERT, JOHN WILLIAM —
18716081 SPLIT-GATE SILICON CARBIDE DEVICE WITH BURIED FIELD LIMITING RING AND PREPARATION METHOD THEREOF ABEL, GARY ROBERT —
18285915 METHOD FOR PREPARING DEUTERATED CHEMICAL BY MEANS OF DEUTERATION REACTION OF CARBON-HYDROGEN BOND WITH DEUTERIUM GAS UNDER CATALYSIS OF ALKALI HERNANDEZ, JACKSON J —
17437968 METHOD FOR SCREENING COMPOUND FOR TREATING OR PREVENTING POLYQ-RELATED NEURODEGENERATIVE DISEASES WANG, CHANG YU —

Top Art Units

Art UnitApps
1691 2
1615 1
2897 1
1623 1
2154 1
1627 1
1618 1
1675 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18885576 Three-dimensional model of exposed microbial membranes at gas-liquid interface and preparation method thereof MEAH, MOHAMMAD Y — §112 Non-Final OA — Pending Sep 14, 2024
18717525 SMALL MOLECULE TRACERS BINDING TO ALPHA-SYNUCLEIN AGGREGATES AND THEIR USES LIPPERT, JOHN WILLIAM 1615 §103§112 Non-Final OA — Pending Jun 07, 2024
18716081 SPLIT-GATE SILICON CARBIDE DEVICE WITH BURIED FIELD LIMITING RING AND PREPARATION METHOD THEREOF ABEL, GARY ROBERT 2897 §103§112 Non-Final OA — Pending Jun 03, 2024
18707314 COMPOUNDS HAVING ACTIVITY OF DEGRADING GSPT1 AND APPLICATION THEREOF BAUER, BRIANNA LEE 1623 §102§103§112 Non-Final OA — Pending May 03, 2024
18625907 DEVICE AND METHOD FOR ON-LINE CONTINUOUS RECOVERY OF EXCESS NITRIC ACID IN NITRATION REACTION MOUDOU, EILEEN QI-YUN — §103 Non-Final OA — Pending Apr 03, 2024
18520221 DATA SEARCH METHOD AND APPARATUS, AND DEVICE ALLEN, NICHOLAS E 2154 §101§103§112 Final Rejection 21d Pending Nov 27, 2023
18285915 METHOD FOR PREPARING DEUTERATED CHEMICAL BY MEANS OF DEUTERATION REACTION OF CARBON-HYDROGEN BOND WITH DEUTERIUM GAS UNDER CATALYSIS OF ALKALI HERNANDEZ, JACKSON J 1627 §103§112 Non-Final OA — Pending Oct 06, 2023
18276365 TOTAL SYNTHESIS METHOD FOR VITAMIN A AND DERIVATIVE THEREOF AND DEUTERATED COMPOUND THEREOF SAWYER, JENNIFER C 1691 §112 Non-Final OA — Pending Aug 08, 2023
18275291 PREPARATION METHOD FOR TETRA-SUBSTITUTED ALLENOIC ACID COMPOUND BASED ON PALLADIUM CATALYTIC SYSTEM SAWYER, JENNIFER C 1691 §103§112Other Non-Final OA — Pending Aug 01, 2023
18304987 USE OF FOLIC ACID AND FOLATE MODIFICATION IN INDUCING B-CELL IMMUNE TOLERANCE AND TARGETING mIgM-POSITIVELY-EXPRESSED B-CELL LYMPHOMA MEJIAS, SAMANTHA LEE 1618 §102§103§112 Non-Final OA 88d overdue Pending Apr 21, 2023
17437968 METHOD FOR SCREENING COMPOUND FOR TREATING OR PREVENTING POLYQ-RELATED NEURODEGENERATIVE DISEASES WANG, CHANG YU 1675 §112 Non-Final OA — Pending Sep 10, 2021

Managing Fudan University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month